BioStar Capital
VC Fund
Petoskey, United States
BioStar Capital is a VC fund in Petoskey focused on Medical Device and Health Care. BioStar Ventures is a venture capital company that offers private equity investment services to firms in the medical device technology services industries. It was founded in 2003 by Louis Cannon and is based in Michigan.
- Total investments:
- 52
- Last investment:
- Lead investor:
- 35%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries BioStar Capital invests in
Stages BioStar Capital invests in
Countries BioStar Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hank Kucheman
|
|||
David J. Brophy
|
|||
Louis Cannon
|
|||
Mark Toland
|
Investment Focus
Industry
- Medical Device 24 (46%)
- Health Care 22 (42%)
- Medical 14 (27%)
- Biotechnology 11 (21%)
- Manufacturing 7 (13%)
Stage
- Series B 17 (33%)
- Series C 7 (13%)
- Series A 5 (10%)
- Series D 4 (8%)
- Series F 2 (4%)
Country
- United States 26 (50%)
- Israel 2 (4%)
- Italy 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hank Kucheman
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
David J. Brophy
Director
|
Director | Total investments: 0 | Find email | |
Lisa Riedmiller
Controller
|
Controller | Total investments: 0 | Find email | |
|
Louis Cannon
Founder & Senior Managing Director
|
Founder & Senior Managing Director | Total investments: 11 | Find email | |
|
Mark Toland
Partner and EIR
|
Partner and EIR | Total investments: 2 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Field Medical
|
Field Medical blends passion and experience to advance cardiac care helping physicians, cardiologists, and patients to achieve the best possible outcomes during cardiac ablation procedures. | $35M / Series B / Jul 01, 2025 | |
Nectero Medical
|
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States. | $96M / Series D / Apr 11, 2024 | |
MMI
|
We believe that all patients deserve the most innovative, open surgical treatment options so they can live their fullest lives. We’re on a mission to advance robotic technology that pushes the limits of soft tissue open surgery and opens new opportunities for surgeons to restore quality of life for more patients with complex conditions. TheSymani® Surgical System is a first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery to restore quality of life for more patients. | $110M / Series C / Feb 21, 2024 | |
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $8.8M / Series B / Apr 04, 2023 | |
|
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $8.8M / Series B / Apr 04, 2023 | |
|
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $8.8M / Series B / Apr 04, 2023 | |
|
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $20M / Series B / Jan 05, 2023 | |
|
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $20M / Series B / Jan 05, 2023 | |
|
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $20M / Series B / Jan 05, 2023 | |
|
Amplitude Vascular Systems
|
Amplitude Vascular Systems is a medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2020 and is based in Ann Arbor, Michigan. | $1.2M / Series A / Oct 26, 2022 | |
| See all 52 investments → | |||
Co-Investors
CUE Growth Partners
4 deals together
Deerfield
4 deals together
MedFocus Fund
4 deals together
Portfolia
4 deals together
Safeguard Scientifics
4 deals together
Triventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does BioStar Capital invest in?
BioStar Capital invests primarily in Medical Device, Health Care and Medical startups, most often at Series B and Series C stage. Most of the 52 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BioStar Capital?
Public channels for BioStar Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BioStar Capital?
The team at BioStar Capital includes Hank Kucheman (Managing Director), David J. Brophy (Director) and Lisa Riedmiller (Controller), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
